Cytological, histological, and clinical correlations in intravesical Bacillus Calmette-Guerin immunotherapy

Annals of Diagnostic Pathology

Volumn 2, Issue 1, 1998, Pages 55-60

  Bedrossian, Carlos ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bcg therapy; Carcinoma; Urothelial

Indexed keywords

ARTICLE; BIOPSY; BLADDER; BLADDER TUMOR; CARCINOMA; CYTOLOGY; FOLLOW UP; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INFLAMMATION; INTRAVESICAL DRUG ADMINISTRATION; LAVAGE; MYCOBACTERIUM BOVIS; PATHOLOGY; PREDICTION AND FORECASTING; TREATMENT OUTCOME; TUMOR RECURRENCE; URINE; UROTHELIUM;

ADMINISTRATION, INTRAVESICAL; BIOPSY; CARCINOMA; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; INFLAMMATION; IRRIGATION; MYCOBACTERIUM BOVIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS; URINE; UROTHELIUM;

EID: 0031988054     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1092-9134(98)80034-8     Document Type: Article

References (2)

1. Erton M, Ilker Y, Akdas P: Carcinoma in situ and treatment options. Intl Urol Nephrol 1996;28:33-42
2. Okamura T, Tozawa K, Yamada Y, et al: Glinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer. J Urol 1996;156:967-971